Protocol: Carboplatin/Gemcitabine
Department of Medical Oncology Chemotherapy Protocols 3rd Edition 2 Protocol: Cisplatin/Gemcitabine Indications: Lung Cancer (non-small cell) – Adjuvant, Neoadjuvant
Download Protocol: Carboplatin/Gemcitabine
Information
Domain:
Source:
Link to this page:
Documents from same domain
Protocol: ABVD - Mid-Western Cancer Centre
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 84 Protocol: ABVD Indications: Hodgkin’s disease Schedule:
Protocol: Doxorubicin/Cisplatin - Mid-Western …
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 78 Protocol: Doxorubicin/Cisplatin Indications: Osteosarcoma - neoadjuvant
Protocol: PCV (Procarbazine/CCNU/Vincristine)
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 100 Protocol: PCV (Procarbazine/CCNU/Vincristine) Indication: Brain Tumours – Palliative
Protocol: BEP 3-day (Bleomycin/Etoposide/Cisplatin)
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 64 Protocol: Carboplatin Indications: Seminoma – stage 1 adjuvant
Protocol: AC (Doxorubicin/Cyclophosphamide)
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 19 Protocol: Paclitaxel Indications: Breast Cancer – Adjuvant (high risk), Palliative
Department of Medical Oncology Chemotherapy …
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 113 Mesna Dose Guidelines (RKG/OF/MK – December 05)
Protocol: CF (Cisplatin/5-Fluorouracil)
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 103 Protocol: CF (Cisplatin/5-Fluorouracil) Indications: Head and neck – metastatic, recurrent
Protocol: Carboplatin/Paclitaxel - Mid-Western …
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 57 Protocol: Carboplatin Indications: Ovarian Cancer – Advanced, Recurrent
Related documents
WHO monographs on selected medicinal plants
apps.who.intWHO monographs on selected medicinal plants iv Radix Valerianae 267 Rhizoma Zingiberis 277 Annex Participants in the WHO Consultation on Selected Medicinal
処方箋医薬品：注意－医師等の処方箋により使用すること 抗 …
database.japic.or.jp【 禁忌（次の患者には投与しないこと） 】 1．出血している患者（血友病、頭蓋内出血、消化管 出血、尿路出血、喀血、硝子体出血等）[出血を助
ポラプレジンクOD錠75mg「JG」
database.japic.or.jp＊2016年12月改訂（第2版）b 2016年12月作成 日本標準商品分類番号 87 2329 亜鉛含有胃潰瘍治療剤 （ポラプレジンク口腔内崩壊錠）
リリカカプセル25mg リリカカプセル75mg リリカカプセ …
www.info.pmda.go.jp- 1 - 患者向医薬品ガイド 2018年2月更新 リリカカプセル25mg リリカカプセル75mg リリカカプセル150mg リリカOD錠25mg
New Zealand Data Sheet APO-CLOPIDOGREL Clopidogrel ...
www.medsafe.govt.nzNew Zealand Data Sheet APO-CLOPIDOGREL Clopidogrel Bisulfate tablets 75mg Please refer to Medsafe website (www.medsafe.govt.nz) for the most recent datasheet Page 1 of 24 Presentation
Dispersible Aspirin 75mg Tablets BP PL 17907 0155-6
www.mhra.gov.ukMHRA PAR – Dispersible Aspirin 75mg Tablets BP (PL 17907/0155-6) - 2 - DISPERSIBLE ASPIRIN 75MG TABLETS BP PL 17907/0155-6 LAY SUMMARY The MHRA granted Bristol Laboratories Limited Marketing Authorisations (licences) for
Zopiclone 3.75mg and 7.5mg Tablets - Medicines
www.medicines.org.ukeaet eel ed Prole T) imensions : o mponent: ate ent: Technologist: Date sent: ecnicall pprov ed Pharmacode: J o .: Zopiclone Tablets 3.75 7.5mg s )